These findings emphasize the potential benefits of integrating the S100B protein and IL-1 beta into risk stratification models, fostering more precisely early intervention strategies for individuals at high risk of experiencing cerebral edema post-stroke. The gene discussed is IL1B; the disease is brain edema.